← All trials
NCT05178953
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2021
- Primary completion
- Jan 8, 2022
- Completion date
- Jan 20, 2022
- First posted
- Jan 5, 2022
- Last posted
- Jan 5, 2022
- Enrollment
- 160
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Arak University of Medical SciencesLead sponsor
- Arak University of Medical SciencesOverall official - principal investigator
- Arak University of Medical SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.